ENDV (Endonovo Therapeutics) Total Assets: $0.02 Mil (As of Jun. 2025)


What is Endonovo Therapeutics Total Assets?

Endonovo Therapeutics ENDV -99.00% Total Assets is $0.02 Mil as of Jun. 2025. The stock has 3 warning signs investors should review.

Endonovo Therapeutics's Total Assets for the quarter that ended in Jun. 2025 was $0.02 Mil.

During the past 12 months, Endonovo Therapeutics's average Total Assets Growth Rate was -94.20% per year. During the past 3 years, the average Total Assets Growth Rate was -78.90% per year. During the past 5 years, the average Total Assets Growth Rate was -58.30% per year. During the past 10 years, the average Total Assets Growth Rate was 0.20% per year.

During the past 13 years, Endonovo Therapeutics's highest 3-Year average Total Assets Growth Rate was 364.90%. The lowest was -78.90%. And the median was -17.90%.

Total Assets is connected with ROA %. Endonovo Therapeutics's annualized ROA % for the quarter that ended in Jun. 2025 was -12,400.00%. Total Assets is also linked to Revenue through Asset Turnover. Endonovo Therapeutics's Asset Turnover for the quarter that ended in Jun. 2025 was 0.00.

Endonovo Therapeutics  (OTCPK:ENDV) Total Assets Explanation

Total Assets is connected with ROA %.

Endonovo Therapeutics's annualized ROA % for the quarter that ended in Jun. 2025 is

ROA %=Net Income (Q: Jun. 2025 )/( (Total Assets (Q: Mar. 2025 )+Total Assets (Q: Jun. 2025 ))/ count )
=-2.232/( (0.018+0.018)/ 2 )
=-2.232/0.018
=-12,400.00 %

Note: The Net Income data used here is four times the quarterly (Jun. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Endonovo Therapeutics's Asset Turnover for the quarter that ended in Jun. 2025 is

Asset Turnover
=Revenue (Q: Jun. 2025 )/( (Total Assets (Q: Mar. 2025 )+Total Assets (Q: Jun. 2025 ))/ count )
=0/( (0.018+0.018)/ 2 )
=0/0.018
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Endonovo Therapeutics Total Assets Related Terms

Endonovo Therapeutics Total Assets Historical Data

* Premium members only.

The historical data trend for Endonovo Therapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Endonovo Therapeutics Total Assets Chart

Endonovo Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.61 2.01 1.28 0.64 0.02

Endonovo Therapeutics Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.15 0.02 0.02 0.02

Endonovo Therapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Endonovo Therapeutics's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (A: Dec. 2024 )+Total Liabilities (A: Dec. 2024 )
=-26.804+26.822
=0.02

Endonovo Therapeutics's Total Assets for the quarter that ended in Jun. 2025 is calculated as

Total Assets=Total Equity (Q: Jun. 2025 )+Total Liabilities (Q: Jun. 2025 )
=-27.824+27.842
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $0.02 Mil mean?
Endonovo Therapeutics (ENDV) has a Total Assets of $0.02 Mil as of Jun. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Endonovo Therapeutics and its competitors.
Is Endonovo Therapeutics' Total Assets too high?
Endonovo Therapeutics' current Total Assets is $0.02 Mil.
How does Endonovo Therapeutics' Total Assets compare to RGBP and IOBTQ?
Endonovo Therapeutics' Total Assets of $0.02 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Endonovo Therapeutics and its competitors. Endonovo Therapeutics's current Total Assets is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Endonovo Therapeutics stock overvalued right now?
Endonovo Therapeutics (ENDV) has a current Total Assets of $0.02 Mil. The current Total Assets is $0.02 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Endonovo Therapeutics (ENDV), the current Total Assets is $0.02 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Endonovo Therapeutics Business Description

Address 6320 Canoga Avenue, 15th Floor, Woodland Hills, CA, USA, 91367
Endonovo Therapeutics Inc develops, manufactures and distributes revolutionary medical devices that utilize Pulsed Electro Magnetic Field (PEMF) therapy that are focused on the rapid recovery of wounds and reduction of pain, edema and inflammation on and in the human body.